5001842026-04-012026-06-305001842026-06-305001842026-04-012026-06-30in-capmkt:OtherExpenses1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments2Member5001842026-04-012026-06-30in-capmkt:ReportableSegments3Member5001842026-04-012026-06-30in-capmkt:ReportableSegments1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments2Member5001842026-04-012026-06-30in-capmkt:ReportableSegments3Member5001842026-04-012026-06-30in-capmkt:ReportableSegments1Member5001842026-06-30in-capmkt:ReportableSegments1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments2Member5001842026-06-30in-capmkt:ReportableSegments2Member5001842026-04-012026-06-30in-capmkt:ReportableSegments3Member5001842026-06-30in-capmkt:ReportableSegments3Member5001842026-04-012026-06-30in-capmkt:ReportableSegments1Member5001842026-06-30in-capmkt:ReportableSegments1Member5001842026-04-012026-06-30in-capmkt:ReportableSegments2Member5001842026-06-30in-capmkt:ReportableSegments2Member5001842026-04-012026-06-30in-capmkt:ReportableSegments3Member5001842026-06-30in-capmkt:ReportableSegments3Member5001842026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss15001842026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss25001842026-04-012026-06-30ItemsThatWillBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500184HSCLNOTLISTEDINE019C01026Himadri Speciality Chemical LimitedMain BoardEquity2026-04-012027-03-312026-07-152026-07-08INRCroresQuarterlyFirst quarterMulti segment2026-07-1511:30:002026-07-1515:25:00Not applicable2026-04-012026-06-30UnauditedConsolidated1431880000056310000014881900000100334000001146400000-205870000058270000022410000021300000017359000001187680000030051000000300510000061730000010350000072080000002284300000000022843000005580000023401000002295200000-109000002351600000-1150000050450000014.554.55004.554.551. The above unaudited consolidated financial results have been reviewed by the Audit Committee and approved by the Board of Directors in their respective meetings held on 15 July 2026. A Limited Review of these consolidated financial results for the quarter ended 30 June 2026 has been carried out by the Statutory Auditors, as required under Regulation 33 of SEBI (LODR) Regulations, 2015. <br /> 2. Other expenses includes foreign exchange fluctuation loss/ (gain) (net) of Rs 25.20 crores for the quarter ended 30 June 2026, Rs 38.13 crores for the quarter ended 31 March 2026, Rs (9.76) crores for the quarter ended 30 June 2025 and Rs 43.56 crores for the year ended 31 March 2026. <br /> 3. Based on the guiding principles given in Ind AS 108 on 'Operating Segments', the Group's business activity falls within following operating segments, namely: (a) Carbon materials and chemicals, and (b) Power (c) Others (includes Mining and Other business) <br /> 4. The consolidated financial results are prepared in accordance with the principles and procedures for the preparation and presentation of consolidated financial results as set out in Ind AS 110 'Consolidated Financial Statements' notified by Ministry of Corporate Affairs. <br /> The consolidated financial results of Himadri Speciality Chemical Limited (the Holding Company or the Parent), include its subsidiaries, namely AAT Global Limited, Shandong Dawn Himadri Chemical Industry Limited, Himadri Speciality Inc, Himadri Agro Tech Specialities Limited (formerly Combe Projects Private Ltd. and Combe Projects Ltd.), Himadri Clean Energy Limited, Himadri Future Material Technology Limited, Invati Creations Private Limited, Himadri Green Technologies Innovation Limited, Birla Tyres Limited (w.e.f 01 April 2025), Himadri Birla Tyre Manufacturer Private Limited (w.e.f 01 April 2025), Trancemarine and Confreight Logistics Private Limited (w.e.f 04 April 2025), Sturdy Niketan Private Limited (w.e.f 04 April 2025), Himadri Advance New Energy Material Limited (formerly, Elixir Carbo Private Ltd. and Elixir Carbo Ltd.) (w.e.f 22 April 2025) and Himadri Integrated Minerals And Resources Limited (formerly, Himadri Power Ltd.) (w.e.f 11 February 2026) (the Holding Company or the Parent and its subsidiaries together referred to as the 'Group'), combined on a line-by-line basis by adding together the book values of like items of asset and liabilities, income and expenses eliminating intra-group balances and transactions and resulting unrealised gains/ (losses). <br /> The consolidated financial results are prepared applying uniform accounting policies on all material items. <br /> 5. The Nomination and Remuneration Committee of the Holding Company at its meeting held on 6 July 2026, has allotted 19,000 equity shares of Re 1 each (Under Grant II) to the option grantees pursuant to exercise of options under the Holding Company’s “Himadri Employee Stock Option Plan 2016”. As a result of such allotment, the paid up equity share capital of the Holding Company has increased from 50,45,41,599 equity shares to 50,45,60,599 equity shares of face value of Re 1 each. <br /> 6. The consolidated figures for the three months ended 31 March 2026 as reported in these consolidated financial results are the balancing figures between audited figures in respect of the full financial year and the published year to date consolidated figures up to the end of the nine months of the relevant financial year. Also the consolidated figures up to the third quarter had only been reviewed and not subjected to audit. <br /> 7. Earnings per share is not annualised for the quarter ended 30 June 2026, 31 March 2026 and 30 June 2025.Other expenses1735900000(A) Carbon materials and chemicals12789000000(b) Power318800000(c) Others14389000001454670000022790000014318800000(A) Carbon materials and chemicals2625600000(b) Power281000000(c) Others115000002918100000224100000-3111000003005100000(A) Carbon materials and chemicals42633100000(b) Power1017800000(c) Others3197100000468480000001991380000066761800000(A) Carbon materials and chemicals1518400000(b) Power10700000(c) Others65110000021802000001502430000017204500000 Other unallocable expenses net of unallocable income includes other income and foreign exchange loss/ (gain) (net), fully unallocableRemeasurement of the net defined benefit plan-500000Net gain/(loss) on investment in equity instruments accounted at fair value37500000370000005200000Exchange difference in transalating financial statements of foreign operations2400000024000000055800000